These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8482464)

  • 1. Propafenone-induced liver injury: report of a case and review of the literature.
    Mondardini A; Pasquino P; Bernardi P; Aluffi E; Tartaglino B; Mazzucco G; Bonino F; Verme G; Negro F
    Gastroenterology; 1993 May; 104(5):1524-6. PubMed ID: 8482464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatic toxicity of propafenone: a case description].
    La Brocca A
    Ann Ital Med Int; 2002; 17(4):261-4. PubMed ID: 12532566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute cholestatic hepatitis caused by propafenone. Report of a case and review of the literature].
    Gandolfi A; Rota E; Zanghieri G; Tolomelli S; Bagnulo A; Mengoli M
    Recenti Prog Med; 2001 Mar; 92(3):197-9. PubMed ID: 11320851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propafenone hepatotoxicity: report of a new case and review of the literature.
    Younan LB; Barada KA; Faraj WG; Tawil AN; Jabbour MN; Khoury MY; El-Majzoub NM; Eloubeidi MA
    Saudi J Gastroenterol; 2013; 19(5):235-7. PubMed ID: 24045598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propafenone-induced drug fever in the absence of agranulocytosis.
    O'Rourke DJ; Palac RT; Holzberger PT; Gerling BR; Greenberg ML
    Clin Cardiol; 1997 Jul; 20(7):662-4. PubMed ID: 9220185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propafenone-related cholestatic hepatitis in an elderly patient.
    Grieco A; Forgione A; Giorgi A; Miele L; Gasbarrini G
    Ital Heart J; 2002 Jul; 3(7):431-4. PubMed ID: 12189974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propafenone hepatotoxicity: report of two new cases.
    Cocozzella D; Curciarello J; Corallini O; Olivera A; Alburquerque MM; Fraquelli E; Zamagna L; Olenchuck A; Cremona A
    Dig Dis Sci; 2003 Feb; 48(2):354-7. PubMed ID: 12643615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Liver function test impairment induced by propafenone in a 73 year old woman].
    Arinzon Z; Fridman R
    Harefuah; 2001 Nov; 140(11):1010-3, 1119. PubMed ID: 11759372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propafenone: an antiarrhythmic come in from the cold.
    Lancet; 1989 Dec 23-30; 2(8678-8679):1490-1. PubMed ID: 2574772
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cholestatic hepatitis following antiarrhythmic propafenone therapy].
    Schuff-Werner P; Kaiser D
    Dtsch Med Wochenschr; 1980 Jan; 105(4):137-8. PubMed ID: 7351197
    [No Abstract]   [Full Text] [Related]  

  • 11. Propafenone-associated Gross Hematuria: A Case Report and Review of the Literature.
    Chen S; Ding W; Ye J; Wang Z; Zhao X; Cui Y
    Clin Ther; 2019 Aug; 41(8):1614-1620. PubMed ID: 31164244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Persistent atrial flutter induced by propafenone (Rytmonorm)].
    Fazekas T; Kiss J; Pap I; Rudas L
    Orv Hetil; 1994 Aug; 135(33):1819-22. PubMed ID: 8072758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placebo-controlled evaluations of propafenone for atrial tachyarrhythmias.
    Rae AP
    Am J Cardiol; 1998 Oct; 82(8A):59N-65N. PubMed ID: 9809902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and tolerability of long-term propafenone therapy for supraventricular tachyarrhythmias. The Propafenone Multicenter Study Group.
    Podrid PJ; Anderson JL
    Am J Cardiol; 1996 Aug; 78(4):430-4. PubMed ID: 8752188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous propafenone in paroxysmal atrial fibrillation: a randomized, placebo-controlled, double-blind, multicenter clinical trial. Paroxysmal Atrial Fibrillation Italian Trial (PAFIT)-2 Investigators.
    Fresco C; Proclemer A; Pavan A; Buia G; Vicentini A; Pavan D; Morgera T
    Clin Cardiol; 1996 May; 19(5):409-12. PubMed ID: 8723601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced antiarrhythmic efficacy of propafenone when used in combination with procainamide or quinidine.
    Klein RC; Huang SK; Marcus FI; Horwitz L; Fenster PE; Rushforth N; Kirsten EB
    Am Heart J; 1987 Sep; 114(3):551-8. PubMed ID: 3630896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Propafenone hepatotoxicity].
    Martín EP; Cervantes JL; Yangüela J
    Rev Esp Enferm Dig; 2004 Oct; 96(10):734-5. PubMed ID: 15537382
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical evidence of the antiarrhythmic effect of a magistral suspension of propafenone: a case report.
    Barranco-Garduño L; Flores-Pérez J; Juárez-Olguín H; Bobadilla-Chávez J; Osnaya H; Flores-Pérez C
    Arch Cardiol Mex; 2009; 79(2):132-4. PubMed ID: 19722384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revisiting propafenone toxicity.
    Alsaad AA; Ortiz Gonzalez Y; Austin CO; Kusumoto F
    BMJ Case Rep; 2017 Apr; 2017():. PubMed ID: 28446489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholestatic hepatitis after diagnostic ajmaline challenge.
    Hamoir C; Dano H; Komuta M; Druez P; Negrin Dastis S
    Acta Gastroenterol Belg; 2017; 80(3):425-426. PubMed ID: 29560676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.